Sino Medical Sciences Technology Past Earnings Performance
Past criteria checks 2/6
Sino Medical Sciences Technology's earnings have been declining at an average annual rate of -12.4%, while the Medical Equipment industry saw earnings declining at 3% annually. Revenues have been growing at an average rate of 5.5% per year. Sino Medical Sciences Technology's return on equity is 0.9%, and it has net margins of 1.3%.
Key information
-12.39%
Earnings growth rate
-13.11%
EPS growth rate
| Medical Equipment Industry Growth | 15.97% |
| Revenue growth rate | 5.45% |
| Return on equity | 0.88% |
| Net Margin | 1.32% |
| Last Earnings Update | 31 Mar 2025 |
Recent past performance updates
Recent updates
Sino Medical Sciences Technology Inc.'s (SHSE:688108) Share Price Matching Investor Opinion
Jan 05
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?
Nov 19Revenues Tell The Story For Sino Medical Sciences Technology Inc. (SHSE:688108) As Its Stock Soars 25%
Sep 24What Sino Medical Sciences Technology Inc.'s (SHSE:688108) P/S Is Not Telling You
Jun 03Optimistic Investors Push Sino Medical Sciences Technology Inc. (SHSE:688108) Shares Up 26% But Growth Is Lacking
Mar 05Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?
Feb 28Revenue & Expenses Breakdown
How Sino Medical Sciences Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 25 | 469 | 6 | 2 | -9 |
| 31 Dec 24 | 459 | 1 | 168 | 141 |
| 30 Sep 24 | 417 | -9 | 160 | 140 |
| 30 Jun 24 | 396 | -7 | 153 | 130 |
| 31 Mar 24 | 361 | -25 | 150 | 124 |
| 31 Dec 23 | 343 | -40 | 156 | 114 |
| 30 Sep 23 | 272 | -95 | 157 | 121 |
| 30 Jun 23 | 244 | -121 | 172 | 124 |
| 31 Mar 23 | 207 | -149 | 178 | 139 |
| 31 Dec 22 | 193 | -162 | 176 | 153 |
| 30 Sep 22 | 239 | -129 | 181 | 153 |
| 30 Jun 22 | 226 | -120 | 167 | 156 |
| 31 Mar 22 | 226 | -119 | 157 | 159 |
| 31 Dec 21 | 194 | -131 | 149 | 149 |
| 30 Sep 21 | 173 | -138 | 145 | 143 |
| 30 Jun 21 | 230 | -90 | 145 | 140 |
| 31 Mar 21 | 283 | -27 | 143 | 120 |
| 31 Dec 20 | 327 | 22 | 139 | 109 |
| 30 Sep 20 | 401 | 73 | 148 | 100 |
| 30 Jun 20 | 404 | 74 | 150 | 93 |
| 31 Mar 20 | 407 | 75 | 158 | 91 |
| 31 Dec 19 | 436 | 90 | 167 | 90 |
| 30 Sep 19 | 419 | 91 | 152 | 86 |
| 31 Dec 18 | 380 | 89 | 142 | 67 |
| 31 Dec 17 | 322 | 66 | 130 | 54 |
| 31 Dec 16 | 266 | 29 | 108 | 76 |
Quality Earnings: 688108 has a large one-off gain of CN¥7.3M impacting its last 12 months of financial results to 31st March, 2025.
Growing Profit Margin: 688108 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688108 has become profitable over the past 5 years, growing earnings by -12.4% per year.
Accelerating Growth: 688108 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 688108 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.6%).
Return on Equity
High ROE: 688108's Return on Equity (0.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 01:16 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sino Medical Sciences Technology Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Zhuo Huang | Everbright Securities Co. Ltd. |